Addus HomeCare (ADUS) Projected to Post Quarterly Earnings on Monday

Addus HomeCare (NASDAQ:ADUS) is projected to release its Q1 2025 earnings data after the market closes on Monday, May 5th. Analysts expect the company to announce earnings of $1.33 per share and revenue of $341.66 million for the quarter.

Addus HomeCare (NASDAQ:ADUS) last issued its quarterly earnings results on Monday, February 24th. The company reported $1.26 earnings per share for the quarter, missing the consensus estimate of $1.35 by ($0.09). Addus HomeCare had a return on equity of 9.62% and a net margin of 6.50%. The business had revenue of $297.14 million for the quarter, compared to the consensus estimate of $291.04 million. On average, analysts expect Addus HomeCare to post $5 EPS for the current fiscal year and $5 EPS for the next fiscal year.

Addus HomeCare Trading Up 1.0 %

Shares of ADUS opened at $105.00 on Friday. The firm has a fifty day simple moving average of $97.46 and a 200 day simple moving average of $115.24. Addus HomeCare has a 12 month low of $88.96 and a 12 month high of $136.72. The stock has a market capitalization of $1.91 billion, a price-to-earnings ratio of 24.03, a PEG ratio of 1.41 and a beta of 0.93.

Analysts Set New Price Targets

ADUS has been the subject of several recent analyst reports. Macquarie reiterated an “outperform” rating and issued a $129.00 target price on shares of Addus HomeCare in a research note on Thursday, February 27th. Oppenheimer boosted their target price on Addus HomeCare from $145.00 to $150.00 and gave the stock an “outperform” rating in a report on Friday, January 24th. Stephens reaffirmed an “overweight” rating and set a $142.00 price objective on shares of Addus HomeCare in a research report on Wednesday, March 12th. JMP Securities reissued a “market outperform” rating and issued a $150.00 price target on shares of Addus HomeCare in a report on Tuesday, April 22nd. Finally, StockNews.com downgraded shares of Addus HomeCare from a “buy” rating to a “hold” rating in a research note on Wednesday, February 26th. One equities research analyst has rated the stock with a hold rating, seven have issued a buy rating and two have assigned a strong buy rating to the stock. According to data from MarketBeat, Addus HomeCare has a consensus rating of “Buy” and an average price target of $139.00.

About Addus HomeCare

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.